Day: March 31, 2021

ImmuneOncia and 3D Medicines Signed Exclusive License Agreement to Develop, Manufacture and Commercialize IMC-002 in Greater China

3D Medicines to Lead the Manufacture, Clinical Development and Commercialization of IMC-002 for Oncology indications in Greater China ImmuneOncia to Receive potentially up to $470.5M including $8M Upfront, and Future Development and Commercial Milestone Payments, plus Tiered Royalties on Net Sales SEOUL, South Korea, March 31, 2021 /PRNewswire/ — ImmuneOncia Therapeutics, Inc., a clinical-stage, immuno-oncology […]

Close to 6 million people across Asia Pacific acquire digital skills during COVID-19Picture 123.jpg

<!–View this article in .txt format–> Microsoft and LinkedIn launch next stage to help job seekers and employers move to a skills-based economy SINGAPORE – Media OutReach – 31 March 2021 – Microsoft Corp. on Tuesday announced it has helped over 30 million people in 249 countries and territories gain access to digital skills, of which close to […]

Back To Top